Compositions of buprenorphine and μ antagonists
作者： Daniel Deaver , Elliot Ehrich
DOI:
关键词: Activity index 、 Buprenorphine 、 Chemistry 、 Opioid receptor 、 Agonist-antagonist 、 Pharmacology 、 Antagonist
摘要: The invention relates to a composition comprising buprenorphine and μ opioid receptor antagonist, wherein the is characterized by an Agonist Antagonist Activity Index (AAnAI) of between about 0.7 2.2; wherein;
lens.org参考文章(70)
J Yardley, Process for preparation of secondary amines from tertiary amines ,(1972)
Mark P. Wentland, Rongliang Lou, Christoph M. Dehnhardt, Wenhu Duan, Dana J. Cohen, Jean M. Bidlack, 3-Carboxamido analogues of morphine and naltrexone: synthesis and opioid receptor binding properties Bioorganic & Medicinal Chemistry Letters. ,vol. 11, pp. 1717- 1721 ,(2001) , 10.1016/S0960-894X(01)00278-5
Harold A. Sackeim, The definition and meaning of treatment-resistant depression. The Journal of Clinical Psychiatry. ,vol. 62, pp. 10- 17 ,(2001)
David J. Eyerman, Thomas Wynn, Daniel R. Deaver, Laura Cook Blumberg, Methods for treating depressive symptoms ,(2014)
Mark P. Wentland, 8-carboxamido-2,6-methano-3-benzazocines ,(2011)
Mark Todtenkopf, Daniel Deaver, Reginald L. Dean, Derrick Arnelle, Selective opioid compounds ,(2009)
Philip M. Pitis, John R. Carson, Carboxamido opioid compounds ,(2005)
Philip S. Portoghese, Andrzej W. Lipkowski, Substituted pyrroles with opioid receptor activity ,(1987)
Robert F. Kaiko, Ramiro Sanchez, Method of administering buprenorphine to treat depression ,(2003)
Edward Kim, Ginger Smith Carls, Yonghua Jing, Wayne N. Burton, Ron Z. Goetzel, Ron Z. Goetzel, J. Erin Bagalman, Quynh Van Tran, Andrei Pikalov, Teresa B. Gibson, Cost burden of treatment resistance in patients with depression. The American Journal of Managed Care. ,vol. 16, pp. 370- 377 ,(2010)